Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccines

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2045-2322
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccines ; volume:8 ; number:1 ; day:24 ; month:4 ; year:2018 ; pages:1-14 ; date:12.2018
Scientific reports ; 8, Heft 1 (24.4.2018), 1-14, 12.2018

Urheber
Altenburg, Arwen F.
Beteiligte Personen und Organisationen
Trierum, Stella E. van
Bruin, Erwin de
Meulder, Dennis de
Sandt, Carolien E. van de
Klis, Fiona R. M. van der
Fouchier, Ron A. M.
Koopmans, Marion P. G.
Rimmelzwaan, Guus F.
Vries, Rory D. de
SpringerLink (Online service)

DOI
10.1038/s41598-018-24820-2
URN
urn:nbn:de:101:1-2018062600093848181038
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:39 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Altenburg, Arwen F.
  • Trierum, Stella E. van
  • Bruin, Erwin de
  • Meulder, Dennis de
  • Sandt, Carolien E. van de
  • Klis, Fiona R. M. van der
  • Fouchier, Ron A. M.
  • Koopmans, Marion P. G.
  • Rimmelzwaan, Guus F.
  • Vries, Rory D. de
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus

Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus

Myotoxicity of telbivudine in pre-existing muscle damage

Myotoxicity of telbivudine in pre-existing muscle damage

LY6D marks pre-existing resistant basosquamous tumor subpopulations

LY6D marks pre-existing resistant basosquamous tumor subpopulations

Theoretically optimal bracing for pre-existing building frames

Theoretically optimal bracing for pre-existing building frames

Recombinant modified Vaccinia Virus Ankara (MVA) vaccines efficiently protect cockatiels against parrot bornavirus infection and proventricular dilatation disease

Recombinant modified Vaccinia Virus Ankara (MVA) vaccines efficiently protect cockatiels against parrot bornavirus infection and proventricular dilatation disease

Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice

Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice

Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics

Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics

Survival of cancer patients with pre-existing heart disease

Survival of cancer patients with pre-existing heart disease

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles

Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates

Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates

Correction: Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates

Correction: Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates

Repair of the Vaccinia virus genes B2R and B3R inhibits interferon production uponmodified Vaccinia virus Ankara infection

Repair of the Vaccinia virus genes B2R and B3R inhibits interferon production uponmodified Vaccinia virus Ankara infection

Verbundene Objekte